ro-106-9920 and benzyloxycarbonylleucyl-leucyl-leucine-aldehyde

ro-106-9920 has been researched along with benzyloxycarbonylleucyl-leucyl-leucine-aldehyde* in 1 studies

Other Studies

1 other study(ies) available for ro-106-9920 and benzyloxycarbonylleucyl-leucyl-leucine-aldehyde

Article	Year
Discovery of novel small molecule cell type-specific enhancers of NF-kappaB nuclear translocation. Bioorganic & medicinal chemistry letters, 2009, Feb-15, Volume: 19, Issue:4 An IKKbeta inhibitor reported to block NF-kappaB transcriptional activities in Jurkat T cells, was found to enhance NF-kappaB translocation in HUVEC cells. These studies suggested a noncanonical NF-kappaB signaling pathway independent of IKKbeta in HUVEC cells. Topics: Combinatorial Chemistry Techniques; Humans; Jurkat Cells; Leupeptins; Molecular Structure; NF-kappa B; Nitriles; Quinazolines; Sulfones; Sulfoxides; Tetrazoles	2009

Article

Year

Discovery of novel small molecule cell type-specific enhancers of NF-kappaB nuclear translocation.

Bioorganic & medicinal chemistry letters, 2009, Feb-15, Volume: 19, Issue:4

An IKKbeta inhibitor reported to block NF-kappaB transcriptional activities in Jurkat T cells, was found to enhance NF-kappaB translocation in HUVEC cells. These studies suggested a noncanonical NF-kappaB signaling pathway independent of IKKbeta in HUVEC cells.

Topics: Combinatorial Chemistry Techniques; Humans; Jurkat Cells; Leupeptins; Molecular Structure; NF-kappa B; Nitriles; Quinazolines; Sulfones; Sulfoxides; Tetrazoles

2009